Categories
- About MIMS Ireland
- New Products
- New Presentations
- New this Month
- Discontinued Products
- New Clinical Evidence
- Clinical Specials
- Irish Medicines Board
- Medicines and Sport
Archives
- December 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- November 2007
- October 2007
Tagcloud
ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome
MIMS Ireland: July 2009
Update on the safety of antipsychotic medicines
01 July 2009 | Irish Medicines Board
Risk of stroke and increased risk of mortality in elderly patients treated for dementia.... Read more
Bramitob
01 July 2009 | New Products
Company: Chiesi Ltd. Legal category: Prescription. HT. Sport Permitted. Active ingredient: Tobramycin 300mg/4ml. Description: Nebuliser solution in single-dose container. Presentation: Price on request. Indication: Management of chronic pulmonary infection due to Pseudomonas aeruginosa in patients with cystic fibrosis aged 6... Read more
Ciplox
01 July 2009 | New Products
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Ciprofloxacin (as HCl) 250mg, 500mg, 750mg. Description: White or yellowish, biconvex, scored film-coated tablets marked C followed by strength. The tablets can be divided into equal halves. Presentation:... Read more
Firmagon
01 July 2009 | New Products
Company: Ferring Ireland Ltd. Legal category: Prescription. Sport permitted. Active ingredient: Degarelix (as acetate) 80mg, 120mg. Description: Powder and solvent for solution for injection. Presentation: 80mg-1; 120mg-2. Prices available on request. Indication: Treatment of adult male patients with advanced hormone-dependent... Read more
Hospira Gemcitabine
01 July 2009 | New Products
Hospital. Sport permitted Hospira Ireland Ltd is pleased to announce the launch of Hospira Gemcitabine to the Irish market. Hospira Gemcitabine is indicated for: • Bladder Cancer: Locally advanced or metastatic bladder cancer in combination with cisplatin. • Breast Cancer:... Read more
Hospira Piperacillin/Tazobactam
01 July 2009 | New Products
Prescription. Sport permitted. Hospira Ireland Ltd is pleased to announce the launch of Piperacillin/Tazobactam Powder for Solution for Injection or Infusion. Piperacillin/Tazobactam is indicated for the treatment of adults and adolescents with moderate to severe systemic and/or local bacterial infections... Read more
Pantoprazole Niche
01 July 2009 | New Products
Company: Niche Generics Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Pantoprazole 20mg, 40mg. Description: Light brownish yellow, oval, slightly biconvex gastro-resistant tablets. Presentation: 20mg-28, €12.03; 40mg-28, €25.50. Indications: Pantoprazole Niche 20mg: Treatment of mild reflux disease and associated... Read more
Phymet DTF
01 July 2009 | New Products
Company: GlaxoSmithKline (Ireland) Ltd. Legal category: Controlled Drug. Sport prohibited. Active ingredient: Methadone HCl, 1mg. Description: Clear green viscous oral solution. Indications: Relief of severe pain in conditions where morphine may be a reasonable alternative, such as severe cancer pain.... Read more
Pipercin
01 July 2009 | New Products
Company: Clonmel Healthcare Ltd. Legal category: Prescription. Sport permitted. Active ingredients: Piperacillin (Na+ salt)/ tazobactam (Na+ salt), 4g/500mg. Description: Powder for solution for injection or infusion. Presentation: 1 vial, price available on request. Indications: Moderate to severe systemic and/or local... Read more
Ranexa
01 July 2009 | New Products
Company: A. Menarini Pharmaceuticals Ireland Ltd. Legal category: Prescription. GMS. Sport pending. Active ingredient: Ranolazine, 375mg, 500mg, 750mg. Description: Respectively, pale blue, light orange, pale green oval-shaped prolonged-release tablets engraved with CVT and strength on one side. Presentations: 375mg-60, €53.37;... Read more
Terbasil
01 July 2009 | New Products
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Terbinafine (HCl) 250mg. Description: White, round, scored, flat tablets marked T above and 1 below the score on one side. The tablet can be divided into equal halves.... Read more
Tredaptive
01 July 2009 | New Products
Company: Merck Sharp & Dohme Ireland (Human Health) Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredients: Nicotinic acid, 1000mg; laropiprant, 20mg. Description: Capsule shaped, white to off white modified-release tablets, with 552 debossed on one side. Presentation: 28, €16.79;... Read more
01 July 2009 | Discontinued Products
Estracombi TTS Discontinued Novartis Ireland Ltd wish to announce the discontinuation of Estracombi TTS patches (Estradiol 50mcg & norethisterone acetate 250mcg / day), pack size 8, from September 2009. For further information please contact Novartis Ireland Ltd at (01) 2601255.... Read more
Lopresor 50mg and 100mg Discontinued
01 July 2009 | Discontinued Products
Novartis Ireland Ltd wish to announce that Lopressor 50mg and 100mg have been discontinued. They also wish to inform of their intention to discontinue Lopresor SR 200mg from August 2009. Should you have any queries, please contact Novartis Ireland Ltd... Read more
